Salivary Markers for Diseases of Periodontium and other Organs

1. Astaneie, F., Afshari, M., Mojtahedi, A. et al: Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients. Arch. Med. Res., 36, 2005, 4, s. 376-381.

2. Belkien, L. D., Bordt, J., Möller, P. et al: Estradiol in saliva for monitoring follicular stimulation in an in vitro fertilization program. Fertil Steril., 44, 1985, 3, s. 322-327.

3. Bodur, A., Badyar, T., Ozmeric, N. at al.: Neopterin profile to evulaute the effectiveness of treatment in aggressive periodontitis. Pteridines, 14, 2003, s. 77-81

4. Booth, V., Zouny, S., Cruchley, A., Taichman, N. S. et al.: Vascular endothelial growth gactor in human periodontal disease status. J. Periodont. Res., 33, 1993, s. 491-499.

5. Britigan, B. E., Edeker, B. L.: Pseudomonas and neutrophil products modify transferrin and lactoferrin to create conditions that favor hydroxyl radical formation. J. Clin. Incest., 88, 1991, s. 1092-1102.

6. Cutando, A., Gómez-Moreno, G., Villalba J. et al: Relationship between salivary melatonin levels and periodontal status in diabetic patients. J. Pineal Res., 35, 2003, s. 239-244.

7. D’Aiuto, F., Parkar, M., Andreou, G. et al: Periodontitis and systemic inflammation: Control of the local infection is associated with a reduction in serum inflammatory markers. J. Dent. Res., 83, 2004, s. 156-160.

8. Diab-Ladki, R., Pellat, B., Chahine, R.: Decrease in the total antioxidant activity of saliva in patients with periodontal diseases. Clin. Oral Investig., 2003, 7, s. 103-107.

9. Elgün, S., Özmeriç, N., Demirtaş, S.: Alanine aminopeptidase and dipeptidyl peptidase IV in saliva: the possible role in periodontal disease. Clinica Chimica Acta, 298, 2000, s. 187-191.

10. Franzmann, E. J., Reategui, E. P., Carraway, K. L. et al: Salivary soluble CD44: a potential molecular marker for head and neck cancer. Cancer Epidemiol Biomarkers Prev., 14, 2005, 3, s. 735-739.

11. Goodyer, I. M, Herbert, J., Tamplin, A.: Psychoendocrine antecedents of persistent first-episode major depression in adolescents: a community-based longitudinal enquiry. Psychol. Med., 33, 2003, 4, s. 601-610.

12. Chambers, D. A., Imrey, P. B., Crawford, J. M. et al: A longitudinal study of aspartate aminotransferase in human gingival grevicular fluid. J. Periodont. Res., 26, 1991, s. 65-74.

13. Ingman, T. Tervahartiala, T., Ding, Y. Tschesche, H., Hadrián, A., Kinane, D. F., Konttinen, Y. T., Sorsa, T.: Matrix metalloproteinases and their inhibit Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patientsors in gingival crevicular fluid and saliva of periodontitis patiens. J. Clin. Periodontol., 23, 1996, s. 1127-11322.

14. Lamster, I. B., Kaufman, E., Grbic, J. T., Winston, L. J.,  Singer, R. E.: βGlucuronidase activity in saliva: Relationship to clinical periodontal parameters. J. of Periodontology, 74, 2003, 3, s. 353-359.

15. Lie, M. A., Loos, B. G., Henskens, Y. M. et al: Salivary cystatin activity and cystatin C in natural and experimental gingivitis in smokers and non-smokers. J. Clin. Periodontol., 28, 2001, s. 979-984.

16. López, M. E., Colloca, M. E., Páez, R. G. et al.: Salivary characteristics of diabetic children. Braz. Dent. J., 14, 2003, 1, s. 26-31.

17. Markoman, M.: Normal CA-125 and the risk of progression in ovarian cancor. Journal of Clinical Oncology, 24, 2006, 20, s. 3310

18. Morenkova, S. A.: Comparative analysis of dependence of saliva sorbitol and fructosamine levels on blood glucose level in patients with diabetes, Biomed. Khim., 50, 2004, s. 612-614.

19. Murakami, Y., Hanazawa, S., Tanaka, S.: Fibronectin in saliva inhibits Porphyromonas gingivalis fimbria-induced expression of inflammatory cytokine gene in mouse macrophages. FEMS Immunol. Med. Microbiol., 22, 1998, s. 257-262.

20. Ohshima, M., Fujikawa, K., Akutagawa, H. et al: Hepatocyte growth factor in saliva a possible marker for periodontal disease status. J. Oral Sci., 44, 2002, s. 35-39.

21. Ozmeriç, N., Nazdar, T., Bodur, A. et al: Level of neopterin, a marker of immune cell activation in gingival crevicular fluid, saliva, and urine in patients with aggressive periodontitis. J. Periodont., 73, 2002, 7, s. 720-725.

22. Ramsey, P. S., Andrews, W. W.: Biochemical predictors of preterm labor: fetal fibronectin and salivary estriol. Clin. Perinatol., 30, 2003, 4, s. 701-733.

23. Rasch, M. S., Mealey, B. L., Prihoda, T. J. et al: The effect of initial periodontal therapy on salivary platelet-activating factor levels in chronic adult periodontitis. J. Periodontol., 66, 1995, 6, s. 613-623.

24. Re, G.et al.: Minerva stomatol., 44, 1995, s. 213-218.

25. Rittmaster, R. S., Thompson, D. L.: Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism. J. Clin. Endocrinol. Metab., 70, 1990, 4, s. 1096-1102.

26. Sculley, D. V, Langley-Evans, S. C.: Periodontal disease is associated with lower antioxidant capacity in whole saliva and evidence of increased protein oxidation. Clinical Science, 105, 2003, s. 167-172.

27. Schmidt, A. M., Weidman, E., Lalla, E. et al: Advanced glycation endproducts (AGEs) induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes. J. Periodontal. Res., 31, 1996, 7, s. 508-515.

28. Simůnková, K., Hampl, R., Hill, M., Doucha, J., Stárka, L., Vondra, K.: Salivary cortisol in low dose (1 microg) ACTH test in healthy women: comparison with serum cortisol. Physiol. Res., 56, 2007, 4, s. 449-453.

29. Streckfus, C. F., Bigler, L., Dellinger, T. et al: The expression of the c-erbB-2 receptor protein in glandular salivary secretions. J. Oral Pathol Med., 33, 2004, 10, s. 595-600.

30. Suomalainen, K., Saxén, L., Vilja, P. et al: Peroxidases, lactoferrin and lysozyme in peripheral blood neutrophils, gingival crevicular fluid and whole saliva of patients with localized juvenile periodontitis. Oral Dis., 2, 1996, 2, s. 129-134.

31. Takane, M., Sugano, N., Iwasaki, H. et al: New biomarker evidence of oxidative DNA damage in whole saliva from clinically healthy and periodontally diseased individuals. J. Periodontol., 73, 2002, s. 551-554.

32. Takane, M., Sugano, N., Ezawa, T. et al: A marker of oxidative stress in saliva: association with periodontally-involved teeth of a hopeless prognosis. J. Oral Sci., 47, 2005, s. 53-57.

33. Tan, D. X., Manchester, L. C., Reiter, R. J. et al.: Significance of melatonin in antioxidative defense system: Reactions and products. Biol Signals Recept., 9, 2000, s. 137-159.

34. Tsai, C. C, Chen, H. S., Chen, S. L. et al: Lipid peroxidation: a possible role in the induction and progression of chronic periodontitis. J. Periodont. Res., 40, 2005, s. 378-386.

35. van Stegeren, A, Rohleder, N, Everaerd, W. et al: Salivary alpha amylase as marker for adrenergic activity during stress: effect of betablockade. Psychoneuroendocrinology, 31, 2006, 1, s. 137-141.

36. van Stein, G. J., Nieuw Amerongen, A. V., Veerman, E. C. I. et al: Effect of periodontal treatment on the activity of chitinase in whole saliva of periodontitis patients. J. Periodont. Res., 37, 2002, s. 245-249.

37. Wolfram, R., Oguogho, A., Palumbo, B. et al: Enhanced oxidative stress in coronary heart disease and chronic heart failure as indicated by an increased 8-epi-PGF(2alpha). Eur J. Heart Fail., 2, 2005, s. 167-172.

38. Xiang, S., Denver, R., Bailey, M. et al: Physiologic determinants of endothelin concentrations in human saliva. Clin. Chem., 49, 2003, s. 2012-2019.

39. Yamada, S.: Assessment of mental condition by saliva level of 3-methoxy-4-hydroxyphenylglycol. Seishin Shinkeigaku Zasshi, 107, 2005, 7, s. 712-717.

40. Zhong, L. P., Chen, G. F., Xu, Z. F. et al: Detection of telomerase activity in saliva from oral squamous cell carcinoma patiens. Int. J. Oral Maxillofac. Surg., 34, 2005, 5, s. 566-570.